中新网上海2月27日电 (张旦昕陈静)上海瑞金医院儿科主任许春娣领衔的课题组首次调研了10年来上海儿童中炎症性肠病的发病情况，完成了国际上首个关于中国儿童中炎症性肠病地区性多中心大样本的临床研究报告。

Beijing, Shanghai, February 27 (xinhua) (Zhang Danxin Chen)Shanghai ruijin hospital group, led by director of pediatric Xu Chundi research for 10 years for the first time Shanghai incidence of inflammatory bowel disease in children,Completed the international first on inflammatory bowel disease in children in China regional multicenter, large sample clinical study.

　　业内专家指出，该研究报告问世将对中国儿童炎症性肠病的诊断和防治起到积极的促进和推动作用，并对建立中国儿童炎症性肠病的诊疗指南提供了理论基础。

Industry experts point out that,The study on Chinese children to diagnosis and treatment of inflammatory bowel disease play a positive promoting and pushing role,And to build a Chinese children of inflammatory bowel disease diagnosis and treatment guidelines provides a theoretical basis.

　　炎症性肠病是一组病因不明的慢性肠道炎症，主要包括溃疡性结肠炎和克罗恩病等。其临床表现主要包括腹泻、血便和腹痛等消化道症状。研究资料显示，炎症性肠病目前尚无根治手段，且其发生肠癌等肿瘤的风险数倍高于正常人，由此严重影响了患者的身体健康和生活质量。以往西方国家的炎症性肠病患病率较高，在我国发病率较低。

Inflammatory bowel disease is a group of unknown etiology of chronic intestinal inflammation,Mainly includes ulcerative colitis and crohn's disease, etc.The main clinical manifestations included diarrhea/Bloody stools and abdominal pain and gastrointestinal symptoms.Research data show,Inflammatory bowel disease means there is no cure,And it happened several times the risk of bowel cancer and other tumors was higher than normal,Thus seriously affect the health and quality of life of patients.In western countries have a higher prevalence of inflammatory bowel disease,Lower rates in our country.

　　许春娣介绍，近年发现，炎症性肠病在中国的发病率也呈逐年上升趋势，正成为中国人群中多发的消化疾病之一。炎症性肠病也多见于儿童，然而在中国却缺乏有关儿童患者的临床研究资料。

Xu Chundi introduction,In recent years found that,The incidence of inflammatory bowel disease in China is a rising trend year by year,Is becoming one of China's multiple digestive disease in the crowd.Inflammatory bowel disease is also found in children,In China, however, a lack of information on children patients with clinical research.

　　据了解，课题组首次联合了上海4所儿童医院的消化科，对近10年来上海儿童炎症性肠病的发病情况进行了较全面的研究和调查。研究结果显示，2000-2010年间上海地区0-14岁炎症性肠病新发人数占申城同年龄段常驻人口的比例逐年上升，发病率从2001年的0.5/100万上升到了2011年的6.1/100万。

We have learned,Team for the first time combined the digestive department of Shanghai children's hospital of 4,Shanghai for nearly 10 years the onset of inflammatory bowel disease in children a more comprehensive research and investigation.The results showed that,From 2000 to 2010 in the Shanghai area 0 to 14, inflammatory bowel disease is the number of new accounts for shen with the age increased year by year the proportion of the resident population,Incidence of 0.5/100 from 2001 rose to 2011 per 6.1/100.

　　该项研究为儿童炎症性肠病的多中心临床研究建立了良好的基础。许春娣表示，课题组将继续致力于对该疾病治疗及转归的观察和研究，并针对该疾病的病因及发病机制作进一步探讨。

The study for inflammatory bowel disease in children of multi-center clinical research has established the good foundation.Xu Chundi said,Group will continue to be committed to the observation and study of the disease, treatment, and outcome,According to the etiology and pathogenesis of the disease for further discussion.

　　据知，国际消化领域权威杂志《炎性肠疾病》(InflammatoryBowelDiseases，IF：4.9)在线发表了许春娣课题组的研究成果。

According to the known,International journal of digestion domain authority[Inflammatory bowel disease](InflammatoryBowelDiseases,The IF:4.9)Published online Xu Chundi research results of the project group.